Alzheimer's disease is the most common cause of dementia, accounting for 60 to 80 percent of all dementia cases worldwide. According to the Alzheimer's Association, approximately 6.9 million Americans aged 65 and older are living with Alzheimer's in 2024, a number projected to reach 12.7 million by 2050 without significant medical breakthroughs. For families navigating this diagnosis, understanding the stages, recognizing symptoms, knowing the available treatments, and learning practical caregiving strategies can make an enormous difference in the quality of life for both the person with Alzheimer's and those who care for them.

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurodegenerative disorder characterized by the accumulation of abnormal protein deposits in the brain: beta-amyloid plaques that form between nerve cells and tau tangles that form inside nerve cells. These deposits disrupt communication between neurons, trigger inflammation, and ultimately cause nerve cell death. The result is a gradual, irreversible decline in memory, thinking, reasoning, and the ability to perform everyday activities.

The National Institute on Aging (NIA) notes that while the greatest known risk factor is advancing age, Alzheimer's is not a normal part of aging. Genetics, particularly the APOE-e4 gene variant, increase risk but do not guarantee the disease. Modifiable risk factors such as cardiovascular disease, diabetes, obesity, smoking, social isolation, and lack of physical and cognitive activity also play important roles. The Lancet Commission on Dementia Prevention estimates that addressing modifiable risk factors could prevent or delay up to 40 percent of dementia cases globally.

The Seven Stages of Alzheimer's Disease

Clinicians commonly use the Reisberg Scale, also known as the Global Deterioration Scale (GDS), to classify Alzheimer's progression into seven stages. Understanding these stages helps families anticipate changes and plan appropriate care.

Stage 1: No Impairment

The disease process may have begun at the cellular level, but there are no outward symptoms. The person functions normally with no detectable memory problems. This stage can last for years or even decades before symptoms emerge.

Stage 2: Very Mild Decline

Minor memory lapses that may be attributed to normal aging, such as forgetting where you put your glasses or blanking on a familiar name. These changes are typically not noticeable to friends, family, or healthcare providers during standard examinations.

Stage 3: Mild Decline

This is often the stage at which family and friends begin to notice problems. The person may struggle to find the right word, have difficulty remembering names of new acquaintances, lose or misplace valuable objects, have trouble planning or organizing, or show decreased performance at work. A clinical interview may detect cognitive deficits at this stage. According to the Alzheimer's Association, Stage 3 can last from two to seven years.

Stage 4: Moderate Decline (Early-Stage Alzheimer's)

At this stage, a careful medical interview can identify clear cognitive deficits. The person may forget recent events, have difficulty with arithmetic (such as counting backward from 100 by 7s), struggle with complex tasks like managing finances or planning a dinner party, and become withdrawn in social situations. Awareness of personal history remains largely intact, but gaps begin to appear. This stage typically lasts about two years.

Stage 5: Moderately Severe Decline (Mid-Stage Alzheimer's)

Major gaps in memory and cognitive function become apparent. The person may be unable to recall their home address, phone number, or the school they attended. Confusion about time and place increases. Help with choosing appropriate clothing for the season or occasion may be needed. However, the person typically still knows their own name and recognizes close family members. Basic activities of daily living such as eating and using the bathroom are generally still manageable without assistance. This stage can last approximately one and a half years.

Stage 6: Severe Decline (Mid-Stage to Late-Stage)

Memory continues to deteriorate significantly. The person may forget the name of a spouse or primary caregiver, though they usually still recognize familiar faces. Assistance with daily activities such as dressing, bathing, and toileting becomes necessary. Behavioral and personality changes may intensify, including suspicion, delusions, compulsive behavior, anxiety, and agitation. Wandering becomes a serious safety concern. Sleep disturbances are common. This stage can last approximately two and a half years.

Stage 7: Very Severe Decline (Late-Stage Alzheimer's)

In the final stage, the person loses the ability to respond to their environment, carry on a conversation, or control movement. Speech may be limited to a few words or phrases. Swallowing difficulties (dysphagia) develop, increasing the risk of aspiration pneumonia. Total assistance with all activities of daily living is required, including feeding, grooming, and mobility. The immune system weakens, making the person vulnerable to infections. According to the NIA, individuals in Stage 7 typically require 24-hour skilled care, either at home or in a specialized memory care facility. This stage lasts from one to three years on average.

Current Treatment Options

While there is no cure for Alzheimer's disease, several treatments can help manage symptoms and, in some cases, slow disease progression.

• Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) work by boosting levels of acetylcholine, a neurotransmitter involved in memory and learning. They are most commonly prescribed for mild to moderate Alzheimer's and can modestly improve cognitive function and daily functioning for some individuals.
• Memantine (Namenda) regulates glutamate, another neurotransmitter, and is typically used for moderate to severe Alzheimer's. It may improve attention, memory, and the ability to perform daily tasks.
• Anti-amyloid therapies represent a newer class of treatments. Lecanemab (Leqembi), approved by the FDA in 2023, targets and removes beta-amyloid plaques from the brain. Clinical trials showed that lecanemab slowed cognitive decline by 27 percent over 18 months compared to placebo. Donanemab, another anti-amyloid antibody, has shown similar promise in clinical trials. These therapies are most effective when administered early in the disease and require regular monitoring for side effects, including brain swelling and microbleeds.
• Non-pharmacological interventions including cognitive stimulation therapy, music therapy, art therapy, light therapy, and structured daily routines can improve mood, reduce agitation, and enhance quality of life at all stages of the disease.

Practical Caregiving Strategies

Caring for a person with Alzheimer's requires patience, flexibility, and ongoing education. The following strategies, recommended by the Alzheimer's Association and the NIA, can help families provide compassionate, effective care:

• Establish predictable routines. Consistency reduces confusion and anxiety. Try to maintain regular schedules for waking, meals, activities, and bedtime.
• Simplify communication. Use short, simple sentences. Ask one question at a time. Give the person plenty of time to respond without rushing or interrupting.
• Create a safe environment. Install locks on cabinets containing hazardous materials, remove tripping hazards, secure sharp objects, and consider a door alarm or GPS tracking device for wandering risk.
• Focus on remaining abilities. Rather than dwelling on what the person can no longer do, engage them in activities they can still enjoy, whether that is listening to music, looking at photo albums, gardening, folding laundry, or taking a walk.
• Manage behavioral symptoms. Agitation, aggression, and sundowning (increased confusion in late afternoon and evening) are common. Identify triggers such as overstimulation, pain, fatigue, or environmental changes. Redirect rather than confront. When possible, consult with a geriatric psychiatrist for behavioral management strategies.
• Prioritize caregiver health. The Alzheimer's Association reports that 35 percent of dementia caregivers say their own health has declined compared to 19 percent of non-caregivers. Seek respite care, join a support group, maintain your own medical appointments, and do not hesitate to ask for help.

Planning for the Future

An Alzheimer's diagnosis should prompt immediate attention to legal and financial planning while the person can still participate in decision-making. Essential documents include a durable power of attorney for finances, a healthcare power of attorney or healthcare proxy, a living will or advance directive, and an updated last will and testament. An elder law attorney experienced with dementia-related issues can help ensure all documents are properly executed.

Conclusion

Understanding Alzheimer's disease, its stages, symptoms, and care requirements, empowers families to face the diagnosis with knowledge and preparation rather than fear. While the disease remains incurable, early diagnosis, available treatments, and thoughtful caregiving can meaningfully improve quality of life for the person with Alzheimer's and their entire family. Education is the first step, and seeking support early makes all the difference.